Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests

Links shared publicly online about this topic.

  • 1,521
    total visits

Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests

sciencedaily.com

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.

View full resource at sciencedaily.com

Tags: Diabetes, Insulin, Type 1 Diabetes, Children's Health

  • Share

Most Recently Shared on December 18, 2009 at 10:34 pm By:

sstrumello Scott Strumello

"Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests": http://bit.ly/5J0Mvk

2 years ago...

Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes

medicalnewstoday.com — “Long-term research is lacking - potential harm remains unclear - valid studies are urgently needed for growing and developing children and adolescentsDue to a lack of suitable stuView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 21, 2009 at 1:07 pm By:

mnt_clinical MNT Clinical Trials Health News

Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1... http://mnt.to/3vK2

2 years ago...

Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests

feeds.sciencedaily.com — “Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.View full resource at feeds.sciencedaily.com

  • View Related
  • Share

Most Recently Shared on December 18, 2009 at 5:05 pm By:

sciencedaily sciencedaily Health News

Rapid-acting insulin analogues: No additional benefit for children with type 1 diabetes, research suggests: Due to ... http://bit.ly/5r7bME

2 years ago...

Advertisement